ENTX logo

Entera Bio Ltd.

ENTX
Healthcare|Biotechnology|IL
$3.14
+0.15 (+5.02%)
DCF Value
$0.14
Tangible Book / Share
$1.89
Graham Number
$0.72
Cash / Share
$1.83
Next Earnings Report
Mar 26, 2027
EPS est. -$0.15
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Aug 28, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Entera Announces Third Quarter 2026 Financial Results and Business Updates
Nov 6, 2026 · GlobeNewsWire
Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors
Oct 27, 2026 · GlobeNewsWire
Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting
Oct 13, 2026 · GlobeNewsWire
Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual Meeting
Oct 8, 2026 · GlobeNewsWire
Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
Oct 6, 2026 · GlobeNewsWire
Correction: Entera to Participate in Upcoming Fall Investor Conferences
Aug 27, 2026 · GlobeNewsWire
Entera to Participate in Upcoming Fall Investor Conferences
Aug 27, 2026 · GlobeNewsWire
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
Aug 18, 2026 · GlobeNewsWire

SEC Filings (63)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 202610-QQuarterly reportDocumentIndex
Nov 6, 20268-KMaterial eventDocumentIndex
Oct 30, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 27, 20268-KMaterial eventDocumentIndex
Oct 14, 2026DEF 14AProxy / shareholder voteDocumentIndex
Oct 6, 20268-KMaterial eventDocumentIndex
Sep 23, 2026PRE 14AProxy / shareholder voteDocumentIndex
Aug 28, 2026EFFECTDocumentIndex
Aug 28, 2026424B3Offering prospectusDocumentIndex
Aug 21, 2026S-3Shelf registrationDocumentIndex
Aug 18, 20268-KMaterial eventDocumentIndex
Aug 12, 2026DDocumentIndex
Aug 7, 2026S-8Employee stock planDocumentIndex
Aug 7, 202610-QQuarterly reportDocumentIndex
Aug 7, 20268-KMaterial eventDocumentIndex
Aug 4, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 4, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 4, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Aug 4, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 4, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 28, 20268-KMaterial eventDocumentIndex
Jul 16, 20268-KMaterial eventDocumentIndex
Jun 3, 2026ARSAnnual report to holdersDocumentIndex
Jun 3, 2026DEFA14AProxy / shareholder voteDocumentIndex
Jun 3, 2026DEF 14AProxy / shareholder voteDocumentIndex
May 15, 2026EFFECTDocumentIndex
May 15, 2026424B3Offering prospectusDocumentIndex
May 14, 2026PRE 14AProxy / shareholder voteDocumentIndex
May 8, 2026S-3Shelf registrationDocumentIndex
May 8, 202610-QQuarterly reportDocumentIndex
May 8, 20268-KMaterial eventDocumentIndex
Apr 3, 20268-KMaterial eventDocumentIndex
Mar 27, 202610-KAnnual reportDocumentIndex
Mar 27, 20268-KMaterial eventDocumentIndex
Mar 4, 20268-KMaterial eventDocumentIndex
Feb 9, 20268-KMaterial eventDocumentIndex
Feb 4, 20268-KMaterial eventDocumentIndex
Nov 14, 202510-QQuarterly reportDocumentIndex
Nov 14, 20258-KMaterial eventDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex